These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 30242638)
1. Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease. Vitale A; Emmi G; Lopalco G; Fabiani C; Gentileschi S; Silvestri E; Di Scala G; Iannone F; Frediani B; Galeazzi M; Lapadula G; Rigante D; Cantarini L Clin Rheumatol; 2019 Jan; 38(1):267. PubMed ID: 30242638 [TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease. Vitale A; Emmi G; Lopalco G; Fabiani C; Gentileschi S; Silvestri E; Gerardo DS; Iannone F; Frediani B; Galeazzi M; Lapadula G; Rigante D; Cantarini L Clin Rheumatol; 2017 Sep; 36(9):2063-2069. PubMed ID: 28401434 [TBL] [Abstract][Full Text] [Related]
3. Correction to: A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry. Gallizzi R; Pidone C; Cantarini L; Finetti M; Cattalini M; Filocamo G; Insalaco A; Rigante D; Consolini R; Maggio MC; Civino A; Martino S; Olivieri AN; Fabio G; Pastore S; Mauro A; Sutera D; Trimarchi G; Ruperto N; Gattorno M; Cimaz R; Pediatr Rheumatol Online J; 2018 Apr; 16(1):29. PubMed ID: 29685142 [TBL] [Abstract][Full Text] [Related]
4. Correction to: Diagnostic efficacy and safety of ultrasound-guided kidney transplant biopsy using cortex-only view: a retrospective single-center study. Shin J; Park SY Eur Radiol; 2019 Aug; 29(8):4523. PubMed ID: 30715583 [TBL] [Abstract][Full Text] [Related]
5. Correction to: Multiple cardiovascular involvements in Behçet's disease: unique utility of Xi XY; Gao W; Guo XJ; Jiang W; Yang YH; Gong JN; Yang MF Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):1989. PubMed ID: 31250084 [TBL] [Abstract][Full Text] [Related]
6. Correction to: Behçet's disease in Egypt: a multicenter nationwide study on 1526 adult patients and review of the literature. Gheita TA; El-Latif EA; El-Gazzar II; Samy N; Hammam N; Abdel Noor RA; El-Shebeiny E; El-Najjar AR; Eesa NN; Salem MN; Ibrahim SE; El-Essawi DF; Elsaman AM; Fathi HM; Sallam RA; El-Shereef RR; Abd-Elazeem MI; Said EA; Khalil NM; Shahin D; El-Saadany HM; ElKhalifa MS; Nasef SI; Abdalla AM; Noshy N; Fawzy RM; Saad E; Moshrif AH; El-Shanawany AT; Abdel-Fattah YH; Khalil HM; Clin Rheumatol; 2019 Sep; 38(9):2649-2650. PubMed ID: 31302857 [TBL] [Abstract][Full Text] [Related]
7. Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease. Park J; Cheon JH Gut Liver; 2018 Nov; 12(6):623-632. PubMed ID: 29788675 [TBL] [Abstract][Full Text] [Related]
8. Switching of anti-TNF-α agents in Behçet's disease. Furuta S; Chow YW; Chaudhry AN; Jayne D Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S62-8. PubMed ID: 23010387 [TBL] [Abstract][Full Text] [Related]
10. Correction to: Short- and long-term outcomes in infective endocarditis patients: a systematic review and meta-analysis. Abegaz TM; Bhagavathula AS; Gebreyohannes EA; Mekonnen AB; Abebe TB BMC Cardiovasc Disord; 2018 Jan; 18(1):5. PubMed ID: 29329514 [TBL] [Abstract][Full Text] [Related]
11. Author Correction: The ASIC3/P2X3 cognate receptor is a pain-relevant and ligand-gated cationic channel. Stephan G; Huang L; Tang Y; Vilotti S; Fabbretti E; Yu Y; Nörenberg W; Franke H; Gölöncsér F; Sperlágh B; Dopychai A; Hausmann R; Schmalzing G; Rubini P; Illes P Nat Commun; 2018 Aug; 9(1):3351. PubMed ID: 30120221 [TBL] [Abstract][Full Text] [Related]
12. Author Correction: Plasmonic meta-electrodes allow intracellular recordings at network level on high-density CMOS-multi-electrode arrays. Dipalo M; Melle G; Lovato L; Jacassi A; Santoro F; Caprettini V; Schirato A; Alabastri A; Garoli D; Bruno G; Tantussi F; De Angelis F Nat Nanotechnol; 2018 Oct; 13(10):972. PubMed ID: 30154426 [TBL] [Abstract][Full Text] [Related]
13. Publisher Correction: Shared strategies for β-lactam catabolism in the soil microbiome. Crofts TS; Wang B; Spivak A; Gianoulis TA; Forsberg KJ; Gibson MK; Johnsky LA; Broomall SM; Rosenzweig CN; Skowronski EW; Gibbons HS; Sommer MOA; Dantas G Nat Chem Biol; 2019 Feb; 15(2):206. PubMed ID: 30591731 [TBL] [Abstract][Full Text] [Related]
14. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease. Accorinti M; Pirraglia MP; Paroli MP; Priori R; Conti F; Pivetti-Pezzi P Jpn J Ophthalmol; 2007; 51(3):191-6. PubMed ID: 17554481 [TBL] [Abstract][Full Text] [Related]
15. Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes. Amer R; Alsughayyar W; Almeida D Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1423-1432. PubMed ID: 28396946 [TBL] [Abstract][Full Text] [Related]
16. Behçet's disease, echocardiographers, and cardiac surgeons: together is better. Farouk H Echocardiography; 2014 Jul; 31(6):783-7. PubMed ID: 25041047 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic criteria of Behçet's disease: problems and suggestions. Lee S Yonsei Med J; 1997 Dec; 38(6):365-9. PubMed ID: 9509905 [TBL] [Abstract][Full Text] [Related]
18. Correction to: Preventive Vertebroplasty for Long-Term Consolidation of Vertebral Metastases. Delpla A; Tselikas L; De Baere T; Laurent S; Mezaib K; Barat M; Nguimbous O; Prudhomme C; Al Ahmar M; Moulin B; Deschamps F Cardiovasc Intervent Radiol; 2020 May; 43(5):807. PubMed ID: 32133554 [TBL] [Abstract][Full Text] [Related]